BioCryst Pharmaceuticals, Inc. (BCRX) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 373.63M | 404.35M | 355.68M | 398.46M | 409.98M | 421.97M | 427.13M | 363.46M | 447.1M | 495.97M | 502.47M | 511.06M | 490.88M | 516.5M | 509M | 494.85M | 511.71M | 566.14M | 252.74M | 265.8M |
| Cash & Short-Term Investments | 238.4M | 274.75M | 212.87M | 260.04M | 295.38M | 321.06M | 330.83M | 272.03M | 336.55M | 388.99M | 397.59M | 410.67M | 398.16M | 424.31M | 426.86M | 417.48M | 443.47M | 507.6M | 199.6M | 218.43M |
| Cash Only | 171.59M | 89.74M | 84.08M | 88.03M | 105.48M | 104.92M | 97.65M | 78.41M | 84.33M | 110.64M | 150.91M | 146.22M | 155.14M | 304.77M | 246.9M | 272.57M | 395.5M | 504.39M | 199.6M | 210.31M |
| Short-Term Investments | 66.81M | 185.01M | 128.79M | 172M | 189.9M | 216.14M | 233.17M | 193.62M | 252.22M | 278.34M | 246.69M | 264.45M | 243.02M | 119.54M | 179.96M | 144.91M | 47.96M | 3.21M | 0 | 8.11M |
| Accounts Receivable | 0 | 106.82M | 91.33M | 91.18M | 93.39M | 79.07M | 72.46M | 68.76M | 60.59M | 56.95M | 53.65M | 57.67M | 48.64M | 50.6M | 42.61M | 41.49M | 36.41M | 29.41M | 26.21M | 27.62M |
| Days Sales Outstanding | - | 22.42 | 52.67 | 51.41 | 53.33 | 52.99 | 55.48 | 53.83 | 57.65 | 54.47 | 59.03 | 58.64 | 64.93 | 53.9 | 51.02 | 54.09 | 59.34 | 54.26 | 60.41 | 41.9 |
| Inventory | 5.99M | 5.4M | 5.23M | 5.04M | 6.87M | 8.09M | 7.56M | 4.45M | 29.78M | 28.68M | 29.63M | 27.03M | 27.47M | 27.53M | 27.02M | 23.38M | 16.14M | 15.79M | 13.66M | 9.85M |
| Days Inventory Outstanding | 0.73 | 49.31 | 187.43 | 193.79 | 147.37 | 117.41 | 171.17 | 916.72 | 2.1K | 1.64K | 2.29K | 2.61K | 2.64K | 1.01K | 641.64 | 7.28K | 6.04K | 3.23K | 1.76K | 1.98K |
| Other Current Assets | 129.24M | 17.38M | 29.75M | 42.2M | 14.33M | 13.75M | 16.28M | 18.22M | 20.18M | 21.35M | 1.58M | 15.69M | 16.62M | 14.06M | 1.44M | 1.45M | 3.35M | 3.35M | 4.3M | 4.35M |
| Total Non-Current Assets | 91.43M | 109.81M | 90.74M | 58.73M | 70.07M | 68.45M | 64.13M | 108.96M | 20.79M | 20.99M | 20.46M | 18.83M | 18.85M | 33.5M | 49.59M | 15.69M | 16.01M | 22.02M | 13.02M | 11.48M |
| Property, Plant & Equipment | 22.98M | 18.99M | 19.24M | 20M | 19.57M | 19.79M | 23.07M | 7.66M | 7.83M | 20.91M | 20.38M | 15.38M | 15.42M | 8.62M | 15.26M | 15.69M | 16.01M | 15.19M | 13.02M | 11.48M |
| Fixed Asset Turnover | 7.45x | 21.27x | 8.12x | 8.25x | 7.40x | 6.14x | 7.62x | 14.11x | 6.45x | 4.52x | 4.85x | 5.36x | 5.72x | 6.66x | 4.90x | 4.14x | 3.20x | 3.34x | 3.35x | 4.51x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 20.57M | 61.16M | 39.67M | 10.1M | 21.95M | 21.72M | 19.43M | 64.32M | 0 | 0 | 0 | 3.44M | 3.43M | 18.08M | 34.33M | 0 | 0 | 6.83M | 0 | 0 |
| Other Non-Current Assets | 47.87M | 29.66M | 31.84M | 28.62M | 28.55M | 26.94M | 21.63M | 36.98M | 12.96M | 80K | 79K | 0 | 0 | 6.81M | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 465.05M | 514.16M | 446.42M | 457.19M | 480.05M | 490.42M | 491.25M | 472.42M | 467.89M | 516.96M | 522.92M | 529.88M | 509.74M | 550M | 558.59M | 510.54M | 527.72M | 588.15M | 265.76M | 277.28M |
| Asset Turnover | 0.32x | 0.85x | 0.35x | 0.35x | 0.30x | 0.27x | 0.24x | 0.23x | 0.19x | 0.18x | 0.16x | 0.16x | 0.13x | 0.14x | 0.14x | 0.13x | 0.09x | 0.11x | 0.15x | 0.18x |
| Asset Growth % | -3.12% | 4.84% | -9.13% | -3.22% | 2.6% | -5.13% | -6.06% | -10.85% | -8.21% | -6.01% | -6.39% | 3.79% | -3.41% | -6.49% | 110.19% | 84.12% | 85.54% | 75.72% | 50.81% | 29.15% |
| Total Current Liabilities | 195.39M | 196.07M | 190.24M | 177.16M | 139.85M | 160.38M | 153.57M | 129.06M | 119.92M | 149.99M | 90.76M | 93.5M | 85.16M | 105.51M | 81.64M | 95.39M | 81.02M | 103.72M | 133.61M | 115.6M |
| Accounts Payable | 10.96M | 15.83M | 5.57M | 8.59M | 10.05M | 11.64M | 13.48M | 7.79M | 11.91M | 20.89M | 10.57M | 13.89M | 6.25M | 14.36M | 8.62M | 12.02M | 13.88M | 27.81M | 19.69M | 10.09M |
| Days Payables Outstanding | 1.71 | 99.24 | 258.2 | 303.08 | 213.7 | 188.52 | 303.08 | 527.47 | 1.18K | 884.03 | 990.3 | 964.74 | 988.75 | 423.47 | 262.86 | 4.77K | 7.88K | 5.21K | 2.23K | 3.13K |
| Short-Term Debt | 3.09M | 40.08M | 37.69M | 0 | 37.17M | 35.45M | 35.89M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30M | 30M |
| Deferred Revenue (Current) | 5.41M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 522K | 1.78M | 1.2M | 1.22M | 1.55M | 1.52M | 1.47M | 1.42M | 602K | 551K |
| Other Current Liabilities | 175.93M | 140.16M | 26.42M | 59.45M | 92.64M | 64.66M | 104.2M | 28.97M | 26.02M | 86.59M | 0 | 0 | 0 | 36.46M | 0 | 0 | 0 | 26.63M | 0 | 0 |
| Current Ratio | 1.91x | 2.06x | 1.87x | 2.25x | 2.93x | 2.63x | 2.78x | 2.82x | 3.73x | 3.31x | 5.54x | 5.47x | 5.76x | 4.90x | 6.23x | 5.19x | 6.32x | 5.46x | 1.89x | 2.30x |
| Quick Ratio | 1.88x | 2.03x | 1.84x | 2.22x | 2.88x | 2.58x | 2.73x | 2.78x | 3.48x | 3.12x | 5.21x | 5.18x | 5.44x | 4.63x | 5.90x | 4.94x | 6.12x | 5.31x | 1.79x | 2.21x |
| Cash Conversion Cycle | - | -27.51 | -18.1 | -57.88 | -13 | -18.11 | -76.42 | 443.08 | 980.64 | 809.04 | 1.36K | 1.7K | 1.71K | 635.79 | 429.8 | 2.56K | -1.78K | -1.93K | -408.64 | -1.11K |
| Total Non-Current Liabilities | 823.5M | 437.25M | 644.08M | 701.62M | 792.12M | 805.97M | 806.25M | 818.96M | 824.14M | 822.5M | 843.15M | 825.1M | 752.87M | 739.08M | 719.62M | 628.38M | 610.92M | 591.42M | 279.2M | 267.76M |
| Long-Term Debt | 12.29M | 427.23M | 633.47M | 690.64M | 782.03M | 795.92M | 796.11M | 808.48M | 813.04M | 811.26M | 833.18M | 819.3M | 746.93M | 733.28M | 713.65M | 144.52M | 604.46M | 585.46M | 132.05M | 126.8M |
| Capital Lease Obligations | 0 | 10.01M | 10.17M | 10.53M | 10.09M | 10.05M | 10.14M | 10.48M | 11.1M | 11.23M | 9.97M | 5.8M | 5.93M | 5.8M | 5.97M | 6.2M | 6.46M | 5.96M | 5.04M | 4.1M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 811.21M | 0 | 436K | 454K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 477.67M | 0 | 0 | 142.11M | 136.86M |
| Total Liabilities | 1.02B | 633.31M | 834.31M | 878.78M | 931.97M | 966.35M | 959.82M | 948.02M | 944.06M | 972.49M | 933.91M | 918.6M | 838.02M | 844.6M | 801.25M | 723.77M | 691.93M | 695.14M | 412.81M | 383.36M |
| Total Debt | 15.39M | 477.33M | 683.11M | 703.18M | 829.29M | 841.42M | 842.14M | 821.67M | 826.88M | 825.15M | 845.43M | 827.63M | 755.36M | 741.45M | 721.81M | 152.85M | 613M | 593.24M | 168.54M | 161.88M |
| Net Debt | -156.2M | 387.59M | 599.03M | 615.14M | 723.81M | 736.5M | 744.48M | 743.26M | 742.54M | 714.5M | 694.52M | 681.41M | 600.22M | 436.69M | 474.91M | -119.72M | 217.5M | 88.85M | -31.06M | -48.44M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | 1.81x | 22.83x | 23.35x | 38.47x | - | 105.23x | 90.48x | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | 1.47x | 20.02x | 20.43x | 33.57x | - | 93.03x | 81.85x | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -35.47x | 18.55x | 1.62x | 1.30x | 1.03x | -0.06x | 0.46x | 0.49x | -0.43x | -1.57x | -0.31x | -1.58x | -0.92x | -1.70x | -0.65x | -1.41x | -2.10x | 0.17x | -3.17x | -2.20x |
| Total Equity | -553.84M | -119.15M | -387.89M | -421.59M | -451.93M | -475.93M | -468.56M | -475.61M | -476.17M | -455.53M | -410.99M | -388.71M | -328.29M | -294.6M | -242.66M | -213.23M | -164.22M | -106.99M | -147.04M | -106.08M |
| Equity Growth % | -22.55% | 74.96% | 17.22% | 11.36% | 5.09% | -4.48% | -14.01% | -22.35% | -45.05% | -54.63% | -69.37% | -82.3% | -99.91% | -175.36% | -65.02% | -101.02% | -118.99% | -455.43% | -537.15% | -238.65% |
| Book Value per Share | -2.29 | -0.54 | -1.76 | -1.92 | -2.10 | -2.29 | -2.26 | -2.30 | -2.31 | -2.26 | -2.17 | -2.06 | -1.74 | -1.58 | -1.30 | -1.15 | -0.89 | -0.59 | -0.82 | -0.60 |
| Total Shareholders' Equity | -553.84M | -119.15M | -387.89M | -421.59M | -451.93M | -475.93M | -468.56M | -475.61M | -476.17M | -455.53M | -410.99M | -388.71M | -328.29M | -294.6M | -242.66M | -213.23M | -164.22M | -106.99M | -147.04M | -106.08M |
| Common Stock | 2.54M | 2.13M | 2.1M | 2.1M | 2.09M | 2.08M | 2.07M | 2.07M | 2.06M | 2.06M | 1.9M | 1.9M | 1.89M | 1.88M | 1.86M | 1.86M | 1.86M | 1.84M | 1.8M | 1.79M |
| Retained Earnings | -2.23B | -1.51B | -1.75B | -1.76B | -1.77B | -1.77B | -1.74B | -1.73B | -1.72B | -1.68B | -1.62B | -1.58B | -1.51B | -1.45B | -1.38B | -1.34B | -1.28B | -1.21B | -1.19B | -1.13B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -368K | 38K | 1.14M | 1.65M | 1.13M | 921K | 2.29M | 557K | 771K | 1.34M | 800K | 690K | 585K | 26K | -98K | 15K | 186K | 177K | 114K | 87K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |